The FTX and Alameda estates have filed an adversary complaint against the FTX Foundation, SBF, Ross Rheingans-Yoo, Nick Beckstead, and some biosciences firms, available here. I should emphasize that anyone can sue over anything, and allege anything in a complaint (although I take complaints signed by Sullivan & Cromwell attorneys significantly more seriously than I take the median complaint). I would caution against drawing any adverse inferences from a defendant's silence in response to the complaint.
The complaint concerns a $3.25MM "philantrophic gift" made to a biosciences firm (PLS), and almost $70MM in non-donation payments (investments, advance royalties, etc.) -- most of which were also to PLS. The only count against Beckstead relates to the donation. The non-donation payments were associated with Latona, which according to the complaint "purports to be a non-profit, limited liability company organized under the laws of the Bahamas[,] incorporated in May 2022 for the purported purpose of investing in life sciences companies [which] held itself out as being part of the FTX Foundation."
The complaint does not allege that either Beckstead or Rheingans-Yoo knew of the fraud at the core of FTX and Alameda.
It does, however, allege (para. 46) that the "transfers were nominally made on behalf of the
FTX Foundation and Latona, but actually were made for the benefit of Bankman-Fried." This is a weak spot in the complaint for me. There's a quote from SBF about needing to do some biosecurity work for PR and political reasons (para. 47), but corporations do charitable stuff for PR and political reasons all the time. There are quotations about wanting to de-emphasize the profit motive / potential in public communications (para. 49-50), but if the profits flowed to a non-profit it's unclear how that would personally enrich SBF.
Quoting Beckstead, the complaint alleges that the investments were "ill-advised and not well-evaluated" (para. 51). It further alleges that there was no, or very little due dilligence (para. 51), such as a lack of any valuation analysis and in most cases lack of access to a data room. As a result, Latona "often paid far more than fair or reasonably equivalent value for the
investments" (para. 52). As for the $3.25MM gift, it was "was made in a similarly slapdash fashion" as the Foundation agreed to it without even knowing whether the recipient was a non-profit (para. 53). There are also allegations about how that gift came to be (para. 53-64).
Paragraph 68 is troubling in terms of Latona's lack of internal controls:
* On May 23, 2022, Rheingans-Yoo sent a Slack message to the Head of
Operations for FTX Ventures, asking her to wire $50 million to PLS on behalf of Latona,
because “Latona doesn’t have a bank account yet, and we’d like to move these funds as soon as possible.” After the Head of Operations inquired why they were wiring $50 million when the SAFE agreement was only for $35 million, Rheingans-Yoo said there was a “separate purchase agreement [that] had a $15mln cash advance.” When the Head of Operations asked for the purchase agreement for $15 million, Rheingans-Yoo replied, “I have an email, no formal agreement,” but “if that’s not sufficient, we can send the 35 first and get the purchase more formally papered.
There apparently wasn't an attempt to formally paper the $15MM until September, and that paper was woefully vague and inadequate if the complaint is credible (para. 70). Likewise, Rheingans-Yoo allegedly offered to send over $3MM to another firm, Lumen, "on a handshake basis" without any paperwork "while we hammer out the full details" (para. 75). However, the funding was not actually sent until an agreement was signed (para. 78-79). A third investment was made on Rheingans-Yoo's recommendation despite Beckstead describing it as "unattractive" for various reasons (para. 82-84).
The "donate, then invest" approach seemed to also be in play with a fourth firm called Riboscience. Paragraph 93 doesn't sound great: "On June 29, 2022, Glenn emailed Rheingans-Yoo that “sufficient time ha[d] passed since the (most generous) donation to the Glenn Labs, that we can now proceed with your desired investment in Riboscience.”
Counts One to Five are similar to what I would expect most clawback complaints would look like. Note that they do not allege any misconduct by the recipients as part of the cause of action, as no such misconduct is necessary for a fraudulent conveyance action. You can also see the bankruptcy power to reach beyond the initial transferee to subsequent transferees under 11 USC 550 at play here. Most of the prefactory material is doubtless there in an attempt to cut off a defense from the defendant biosciences firms that they gave something of reasonably equivalent value in exchange for the investments.
In Count Eleven, the complaint alleges that "Rheingans-Yoo knew that the transactions with the Lifesciences Defendants did not provide and had virtually no prospect of providing Alameda with reasonably equivalent value, and that Bankman-Fried personally benefited from the transactions. Rheingans-Yoo thus knowingly assisted in and/or failed to prevent Bankman-Fried’s breaches of fiduciary duty to Alameda." (para. 169). This allegedly harmed Alameda to the tune of $68.3MM. Elsewhere, the complaint alleges that " [u]pon information and belief, Bankman-Fried and Rheingans-Yoo intended to benefit personally from any profits generated by any of
these companies if they turned out to be successful and/or developed a successful product." (para. 5). However, "upon information and belief" is lawyer-speak for "we're speculating, or at least don't have a clear factual basis for this allegation yet."
In Count Twelve, the complaint alleges that "Beckstead and Rheingans-Yoo knew that the transfer to PLS funded by FTX did not provide and had virtually no prospect of providing FTX with reasonably equivalent value, and that Bankman-Fried personally benefited from the transaction. Beckstead and Rheingans-Yoo thus aided and abetted Bankman-Fried’s breaches of fiduciary duty to FTX." (para. 174). This allegedly harmed FTX to the tune of $3.25MM.
In the end, the complaint doesn't exactly make me think highly of anyone involved with FTX or the FTX Foundation. However, from my non-specialist eyes, I'm not seeing a slam dunk case for critical assertions about Beckstead and Rheingans-Yoo's knowledge in paras. 169 and 174.